Etiologic Diagnosis Algorithm in Infective Endocarditis
Recruiting
N/A
Interventional Study
Infective Endocarditis
Microbiology
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 128 (estimated)
- Sponsor
- I.M. Sechenov First Moscow State Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate the impact of a diagnostic algorithm combining culture-based and molecular methods on the frequency of etiotropic antibiotic therapy prescription within 14 days of diagnosis of infective endocarditis
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Informed consent,
* Age ≥ 18,
* IE (definite or possible per the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis)
Exclusion Criteria:
* Pregnancy/breastfeeding
* Unconfirmed or rejected IE diagnosis,
* Very high risk…
Contacts